Resource utilization before and during infliximab therapy in patients with inflammatory bowel disease

Journal of Medical Economics ◽

10.3111/13696998.2011.625746 ◽

2011 ◽

Vol 15 (1) ◽

pp. 45-52 ◽

Author(s):

Heidi C. Waters ◽

Julie E. Vanderpoel ◽

Bijan Nejadnik ◽

R. Scott McKenzie ◽

Orsolya E. Lunacsek ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Resource Utilization ◽

Bowel Disease ◽

Infliximab Therapy ◽

Inflammatory Bowel

Download Full-text

Importance of trough levels and antibody titers on the efficacy and safety of Infliximab therapy in inflammatory bowel disease

Zeitschrift für Gastroenterologie ◽

10.1055/s-0032-1312407 ◽

2012 ◽

Vol 50 (05) ◽

Author(s):

T Molnár ◽

K Farkas ◽

É Pallagi ◽

R Gyulai ◽

R Kui ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Bowel Disease ◽

Infliximab Therapy ◽

Efficacy And Safety ◽

Antibody Titers ◽

Inflammatory Bowel ◽

Download Full-text

Anti Tumor Necrosis Factor-a Monoclonal Antibody (Infliximab) Therapy in Patients with Inflammatory Bowel Disease (IBD): Applications and Side Effects

Drug Design Reviews - Online ◽

10.2174/1567269043480645 ◽

2004 ◽

Vol 1 (2) ◽

pp. 111-117 ◽

Author(s):

L. Amati ◽

M. Passeri ◽

M. Mastronardi ◽

E. Jirillo

Keyword(s):

Inflammatory Bowel Disease ◽

Monoclonal Antibody ◽

Side Effects ◽

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Infliximab Therapy ◽

Inflammatory Bowel ◽

Necrosis Factor

Download Full-text

Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease

BMC Medicine ◽

10.1186/s12916-017-0949-7 ◽

2017 ◽

Vol 15 (1) ◽

Author(s):

Jacob Tveiten Bjerrum ◽

Casper Steenholdt ◽

Mark Ainsworth ◽

Ole Haagen Nielsen ◽

Michelle AC Reed ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Lipid Profile ◽

Bowel Disease ◽

Infliximab Therapy ◽

Inflammatory Bowel

Download Full-text

Adherence to infliximab therapy in inflammatory bowel disease patients in a real-life setting

Journal of Digestive Diseases ◽

10.1111/1751-2980.12539 ◽

2017 ◽

Vol 18 (10) ◽

pp. 566-573 ◽

Author(s):

Laura Martelli ◽

Anthony Lopez ◽

Sophie Strobel ◽

Silvio Danese ◽

Xavier Roblin ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Bowel Disease ◽

Real Life ◽

Infliximab Therapy ◽

Real Life Setting ◽

Inflammatory Bowel

Download Full-text

839 Response and Healthcare Resource Utilization in Inflammatory Bowel Disease Patients Treated With Either Infliximab or Vedolizumab

The American Journal of Gastroenterology ◽

10.14309/01.ajg.0000592892.03021.99 ◽

2019 ◽

Vol 114 (1) ◽

pp. S485-S485

Author(s):

Harry E. Sarles ◽

Thomas C. Hardin ◽

Samantha A. Kuten ◽

Lucinda J. Van Anglen

Keyword(s):

Inflammatory Bowel Disease ◽

Resource Utilization ◽

Bowel Disease ◽

Healthcare Resource ◽

Healthcare Resource Utilization ◽

Inflammatory Bowel

Download Full-text

Pre-existing IgG antibodies cross-reacting with the Fab region of infliximab predict efficacy and safety of infliximab therapy in inflammatory bowel disease

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.12330 ◽

2013 ◽

Vol 37 (12) ◽

pp. 1172-1183 ◽

Author(s):

C. Steenholdt ◽

Y. Palarasah ◽

K. Bendtzen ◽

A. Teisner ◽

J. Brynskov ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Bowel Disease ◽

Infliximab Therapy ◽

Efficacy And Safety ◽

Igg Antibodies ◽

Inflammatory Bowel

Download Full-text

PSY24 Association of Patient Cost or Reimbursement Challenges With Health Care Resource Utilization, Quality of Life, and Work Productivity Among Patients With Inflammatory Bowel Disease

Value in Health ◽

10.1016/j.jval.2012.03.558 ◽

2012 ◽

Vol 15 (4) ◽

pp. A102-A103

Author(s):

J. Vanderpoel ◽

J. Lofland ◽

B. Schenkel ◽

M.D. Dibonaventura ◽

H. Gross

Keyword(s):

Quality Of Life ◽

Health Care ◽

Inflammatory Bowel Disease ◽

Resource Utilization ◽

Bowel Disease ◽

Work Productivity ◽

Health Care Resource ◽

Health Care Resource Utilization ◽

Inflammatory Bowel

Download Full-text

Infliximab therapy does not worsen heart function in children with inflammatory bowel disease

Digestive and Liver Disease ◽

10.1016/j.dld.2007.07.054 ◽

2007 ◽

Vol 39 (10) ◽

pp. A50

Author(s):

M. Barbato ◽

M. Curione ◽

F. Viola ◽

P. Versacci ◽

F. Parisi ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Bowel Disease ◽

Heart Function ◽

Infliximab Therapy ◽

Inflammatory Bowel

Download Full-text

Su1316 Effects of Patient Annual Adherence of Biologics on Healthcare Resource Utilization for Patients With Inflammatory Bowel Disease

Gastroenterology ◽

10.1016/s0016-5085(14)61562-6 ◽

2014 ◽

Vol 146 (5) ◽

pp. S-434 ◽

Author(s):

Guy David ◽

Peter J. Mallow ◽

Homer Cantu ◽

Jennifer Lofland

Keyword(s):

Inflammatory Bowel Disease ◽

Resource Utilization ◽

Bowel Disease ◽

Healthcare Resource ◽

Healthcare Resource Utilization ◽

Inflammatory Bowel

Download Full-text

Hospitalization Outcomes for Inflammatory Bowel Disease in Teaching vs Nonteaching Hospitals

Inflammatory Bowel Diseases ◽

10.1093/ibd/izz089 ◽

2019 ◽

Vol 25 (12) ◽

pp. 1974-1982 ◽

Author(s):

Rahul S Dalal ◽

Ravy K Vajravelu ◽

James D Lewis ◽

Gary R Lichtenstein

Keyword(s):

Inflammatory Bowel Disease ◽

Resource Utilization ◽

Bowel Disease ◽

Teaching Hospitals ◽

Community Centers ◽

Teaching Status ◽

Inflammatory Bowel ◽

Teaching hospitals are known for higher inpatient costs compared to community centers. We therefore assessed the impact of hospital teaching status on IBD hospitalization outcomes and found that increased resource utilization is driven by disease complexity, not hospital teaching status.

Download Full-text